Correlation Between SAB Biotherapeutics and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Hookipa Pharma, you can compare the effects of market volatilities on SAB Biotherapeutics and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Hookipa Pharma.
Diversification Opportunities for SAB Biotherapeutics and Hookipa Pharma
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between SAB and Hookipa is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Hookipa Pharma go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Hookipa Pharma
Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Hookipa Pharma. In addition to that, SAB Biotherapeutics is 1.89 times more volatile than Hookipa Pharma. It trades about -0.12 of its total potential returns per unit of risk. Hookipa Pharma is currently generating about -0.09 per unit of volatility. If you would invest 195.00 in Hookipa Pharma on December 2, 2024 and sell it today you would lose (42.00) from holding Hookipa Pharma or give up 21.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
SAB Biotherapeutics vs. Hookipa Pharma
Performance |
Timeline |
SAB Biotherapeutics |
Hookipa Pharma |
SAB Biotherapeutics and Hookipa Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SAB Biotherapeutics and Hookipa Pharma
The main advantage of trading using opposite SAB Biotherapeutics and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |